Clinical Trial Update: Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of AC2993 on glucose control in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AC2993 (AC2993)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED